Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Balthaser Kevin
Chief Financial Officer at Aclaris Therapeutics. Filing since 2 Mar 2023.
CIK 0001957554
Company
Date
Role
Action
Shares
Amount
Of holding
ACRS
Aclaris Therapeutics, Inc.
6 Sep 2023
Chief Financial Officer
Bought
9,490
$74.97K
159%
ACRS
Aclaris Therapeutics, Inc.
3 Mar 2023
Chief Financial Officer
Sold, plan not stated
894
$11.29K
14.5%
ACRS
Aclaris Therapeutics, Inc.
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
1,000
$12.29K
17.7%
3 decisions on file.
